4.6 Article

Evidence for ACE2-Utilizing Coronaviruses (CoVs) Related to Severe Acute Respiratory Syndrome CoV in Bats

Journal

JOURNAL OF VIROLOGY
Volume 86, Issue 11, Pages 6350-6353

Publisher

AMER SOC MICROBIOLOGY
DOI: 10.1128/JVI.00311-12

Keywords

-

Categories

Funding

  1. Norman Hackerman Advanced Research Program [003658-0250-2009]
  2. National Institutes of Health [R01-GM-093086]
  3. New England Regional Center for Excellence/Biodefense and Emerging Infectious Disease [U54 AI057159]
  4. New England Primate Research Center [RR000168]
  5. American Cancer Society [120612-PF-11-045-01-DMC]
  6. Burroughs Wellcome Fund

Ask authors/readers for more resources

In 2002, severe acute respiratory syndrome (SARS)-coronavirus (CoV) appeared as a novel human virus with high similarity to bat coronaviruses. However, while SARS-CoV uses the human angiotensin-converting enzyme 2 (ACE2) receptor for cellular entry, no coronavirus isolated from bats appears to use ACE2. Here we show that signatures of recurrent positive selection in the bat ACE2 gene map almost perfectly to known SARS-CoV interaction surfaces. Our data indicate that ACE2 utilization preceded the emergence of SARS-CoV-like viruses from bats.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available